N | 13,594 |

Period length, mean (SD), months | 33.2 (28.1) |

Initial HbA_{1c}, mean (SD), %; mmol/mol | 8.3 (1.6); 67 (12.9) |

Maximum HbA_{1c}, mean (SD), %; mmol/mol | 9.4 (2.0); 79 (16.8) |

Periods where treatment target was reached, n (%) | 8,300 (61.1) |

Rate of HbA_{1c} measurement per month^{−1}, mean (SD) | 0.28 (0.16) |

Rate of lifestyle counseling per month^{−1}, mean (SD) | 0.30 (0.24) |

Rate of medication intensification per month^{−1}, mean (SD) | 0.10 (0.13) |

Periods with patients receiving insulin, n (%) | 4,118 (30.3) |

Periods with patients who are obese (BMI ≥30 kg/m^{2}), n (%) | 7,549 (55.5) |

Documentation heterogeneity, mean (SD)^{a} | 0.69 (0.15) |

Documentation intensity, mean (SD), characters/note | 91 (45) |

↵

^{a}Documentation heterogeneity represented by the normalized Levenshtein distance.